Press Room

Ingenico Group SA Purchases MMP Portfolio™ License 09/28/2015

September 28, 2015 Read more...

Patriot Scientific Corporation Files Annual Report 08/31/2015

August 31, 2015 Read more...

Patriot Settles Litigation with Novatel MMP Portfolio™ License 07/06/2015

July 6, 2015 Read more...

Patriot Scientific Corporation Files Quarterly Report and Provides Legal Update 04/14/2015

April 14, 2015 Read more...

Patriot Scientific Corporation Announces Annual Shareholder Meeting 03/04/2015

March 4, 2015 Read more...

Previously Announced Licensees

Read more...

About Patriot Scientific Corporation

Headquartered in Carlsbad, California, Patriot Scientific Corporation (PTSC) is the co-owner of the Moore Microprocessor Patent Portfolio(TM). For more information on PTSC, visit www.ptsc.com.

Contact: Patriot Investor Relations
ir@ptsc.com
760-547-2700 ext. 102

Certain matters discussed within this web site (including attachments and any documents incorporated by reference) are forward-looking statements intended to qualify for the Safe Harbor from liability established by the Private Securities litigation Reform Act of 1995.

These forward-looking statements can generally be identified as such because the context of the statement will include words such as Patriot Scientific “believes,” “anticipates,” “expects,” or similar words, and such statements are forward looking in time.

Such forward-looking statements involve certain risks, assumptions and uncertainties. In each case, actual results may differ materially from such forward-looking statements. Any statements regarding targets for future results are forward-looking, and actual results may differ materially. These are the company's targets, not predictions of actual performance.

Such forward-looking statements inherently involve risks and uncertainties, including the risks associated with the effect of changing economic conditions, trends in the products markets, variations in the company's cash flow, market acceptance risks, technical development risks, uncertainty of patent and proprietary rights, uncertainty as to royalty payments and indemnification risks, seasonality and other risk factors detailed in the company's Securities and Exchange Commission filings, which should be consulted and considered by you in evaluating any statement contained herein and/or made by Patriot Scientific or on its behalf.

Patriot Scientific does not routinely undertake to publicly update or revise its forward-looking statements, including those that may be included in this web site or in attachments thereto, even if experience or future changes make it clear that any projected results (expressed or modified) will not be realized.